Solana Company (HSDT) reports 52.8M shares and pre-funded warrants

Rhea-AI Filing Summary

Solana Company, formerly known as Helius Medical Technologies, Inc., reported its current capital structure. As of February 20, 2026, the Company has 52,802,604 shares of common stock issued and outstanding. In addition, it has pre-funded warrants outstanding that are exercisable for 23,930,181 shares of common stock.

0001610853false00016108532026-02-202026-02-20

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 20, 2026

SOLANA COMPANY

(Exact name of registrant as specified in its charter)

​

-	​	​
Delaware	001-38445	36-4787690
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)
​	​	​
642 Newtown Yardley Road, Suite 100 Newtown, PA		18940
(Address of principal executive offices)		(Zip Code)

​

Registrant’s telephone number, including area code: (215) 944-6100

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​

​	​
☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

​	​	​ ​	​	​
Title of each class	​ ​ ​	Trading Symbol(s)	​ ​ ​	Name of each exchange on which registered
Class A Common Stock, $0.001 par value	​	HSDT	​	The Nasdaq Stock Market LLC

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

​

​

Item 8.01 Other Events.

​

Solana Company (formerly known as Helius Medical Technologies, Inc.) (the “Company”) today confirmed that as of February 20, 2026, 52,802,604 shares of the Company’s common stock are issued and outstanding, and pre-funded warrants to purchase 23,930,181 shares of the Company’s common stock are issued and outstanding.

​

​

​

​

​

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​

​	​	​	​
​	​	SOLANA COMPANY.
​	​	​	​
Dated: February 20, 2026	​	By:	/s/ Jeffrey S. Mathiesen
​	​	​	Jeffrey S. Mathiesen
​	​	​	Chief Financial Officer, Treasurer and Secretary

​

​

​

3

FAQ

What did Solana Company (HSDT) disclose in this 8-K filing?

Solana Company disclosed its current equity capitalization. As of February 20, 2026, it reported 52,802,604 shares of common stock issued and outstanding and pre-funded warrants outstanding that are exercisable for 23,930,181 additional shares of common stock.

How many Solana Company (HSDT) common shares are outstanding?

Solana Company reported 52,802,604 shares of common stock issued and outstanding as of February 20, 2026. This figure reflects the company’s current equity base and is important for understanding ownership percentages and per-share calculations such as earnings per share.

What pre-funded warrants has Solana Company (HSDT) reported as outstanding?

Solana Company reported pre-funded warrants outstanding that are exercisable for 23,930,181 shares of common stock as of February 20, 2026. These securities, if exercised, would add to the number of shares outstanding and represent potential future dilution for existing shareholders.

Why is Solana Company (HSDT) mentioned as formerly Helius Medical Technologies?

The filing identifies Solana Company as formerly known as Helius Medical Technologies, Inc. This clarifies corporate continuity and helps investors and regulators connect past disclosures, trading history, and regulatory filings under the prior company name with the current Solana Company identity.

What stock exchange lists Solana Company (HSDT) common stock?

Solana Company’s Class A common stock, with a par value of $0.001 per share, is listed on The Nasdaq Stock Market LLC. The filing identifies the company’s trading symbol as HSDT, linking the disclosed capitalization details to the publicly traded security.

Who signed the Solana Company (HSDT) 8-K confirming shares outstanding?

The 8-K was signed on behalf of Solana Company by Jeffrey S. Mathiesen. He is identified in the filing as the company’s Chief Financial Officer, Treasurer and Secretary, confirming the reported capitalization information in his capacity as an authorized officer.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 EX-101.SCH 2.6 KB
• EX-101 EX-101.LAB 15.5 KB
• EX-101 EX-101.PRE 10.1 KB